Literature DB >> 25278676

Immune evasion strategies used by Helicobacter pylori.

Taslima T Lina1, Shatha Alzahrani1, Jazmin Gonzalez1, Irina V Pinchuk1, Ellen J Beswick1, Victor E Reyes1.   

Abstract

Helicobacter pylori (H. pylori) is perhaps the most ubiquitous and successful human pathogen, since it colonizes the stomach of more than half of humankind. Infection with this bacterium is commonly acquired during childhood. Once infected, people carry the bacteria for decades or even for life, if not treated. Persistent infection with this pathogen causes gastritis, peptic ulcer disease and is also strongly associated with the development of gastric cancer. Despite induction of innate and adaptive immune responses in the infected individual, the host is unable to clear the bacteria. One widely accepted hallmark of H. pylori is that it successfully and stealthily evades host defense mechanisms. Though the gastric mucosa is well protected against infection, H. pylori is able to reside under the mucus, attach to gastric epithelial cells and cause persistent infection by evading immune responses mediated by host. In this review, we discuss how H. pylori avoids innate and acquired immune response elements, uses gastric epithelial cells as mediators to manipulate host T cell responses and uses virulence factors to avoid adaptive immune responses by T cells to establish a persistent infection. We also discuss in this review how the genetic diversity of this pathogen helps for its survival.

Entities:  

Keywords:  Antigen presenting cells; Gastric epithelial cells; Helicobacter pylori; Immune response; Pattern recognition receptors; Phagocytes; T cells; T4SS; Vacuolating cytotoxin

Mesh:

Year:  2014        PMID: 25278676      PMCID: PMC4177461          DOI: 10.3748/wjg.v20.i36.12753

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  118 in total

1.  Mutation frequency and biological cost of antibiotic resistance in Helicobacter pylori.

Authors:  B Björkholm; M Sjölund; P G Falk; O G Berg; L Engstrand; D I Andersson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

2.  DC-derived IL-18 drives Treg differentiation, murine Helicobacter pylori-specific immune tolerance, and asthma protection.

Authors:  Mathias Oertli; Malin Sundquist; Iris Hitzler; Daniela B Engler; Isabelle C Arnold; Sebastian Reuter; Joachim Maxeiner; Malin Hansson; Christian Taube; Marianne Quiding-Järbrink; Anne Müller
Journal:  J Clin Invest       Date:  2012-02-06       Impact factor: 14.808

3.  Cathepsin B cleavage of Ii from class II MHC alpha- and beta-chains.

Authors:  V E Reyes; S Lu; R E Humphreys
Journal:  J Immunol       Date:  1991-06-01       Impact factor: 5.422

4.  Helicobacter pylori-induced apoptosis in T cells is mediated by the mitochondrial pathway independent of death receptors.

Authors:  T M Ganten; E Aravena; J Sykora; R Koschny; J Mohr; J Rudi; W Stremmel; H Walczak
Journal:  Eur J Clin Invest       Date:  2007-02       Impact factor: 4.686

5.  Presence of gastric autoantibodies impairs gastric secretory function in patients with Helicobacter pylori-positive duodenal ulcer.

Authors:  F Parente; R Negrini; V Imbesi; G Maconi; M Sainaghi; L Vago; G Bianchi Porro
Journal:  Scand J Gastroenterol       Date:  2001-05       Impact factor: 2.423

6.  Expression of B7-H1 on gastric epithelial cells: its potential role in regulating T cells during Helicobacter pylori infection.

Authors:  Soumita Das; Giovanni Suarez; Ellen J Beswick; Johanna C Sierra; David Y Graham; Victor E Reyes
Journal:  J Immunol       Date:  2006-03-01       Impact factor: 5.422

7.  The neutrophil-activating protein of Helicobacter pylori promotes Th1 immune responses.

Authors:  Amedeo Amedei; Andrea Cappon; Gaia Codolo; Anna Cabrelle; Alessandra Polenghi; Marisa Benagiano; Elisabetta Tasca; Annalisa Azzurri; Mario Milco D'Elios; Gianfranco Del Prete; Marina de Bernard
Journal:  J Clin Invest       Date:  2006-03-16       Impact factor: 14.808

8.  Systemic humoral anti-Helicobacter pylori immune response in patients with gastric malignancies and benign gastroduodenal disease.

Authors:  Nebojsa Manojlovic; Ljubinka Nikolic; Dijana Pilcevic; Jeremija Josifovski; Dragana Babic
Journal:  Hepatogastroenterology       Date:  2004 Jan-Feb

9.  Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells.

Authors:  P Pierre; I Mellman
Journal:  Cell       Date:  1998-06-26       Impact factor: 41.582

10.  Helicobacter pylori-specific antibodies impair the development of gastritis, facilitate bacterial colonization, and counteract resistance against infection.

Authors:  Ali A Akhiani; Karin Schön; Lennart E Franzén; Jacques Pappo; Nils Lycke
Journal:  J Immunol       Date:  2004-04-15       Impact factor: 5.422

View more
  32 in total

Review 1.  Mycobacterium paratuberculosis as a cause of Crohn's disease.

Authors:  Adrienne L McNees; Diane Markesich; Najah R Zayyani; David Y Graham
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2015-10-16       Impact factor: 3.869

2.  Influences of nanocarrier morphology on therapeutic immunomodulation.

Authors:  Molly Frey; Sharan Bobbala; Nicholas Karabin; Evan Scott
Journal:  Nanomedicine (Lond)       Date:  2018-08-07       Impact factor: 5.307

Review 3.  Helicobacter pylori in human health and disease: Mechanisms for local gastric and systemic effects.

Authors:  Denisse Bravo; Anilei Hoare; Cristopher Soto; Manuel A Valenzuela; Andrew Fg Quest
Journal:  World J Gastroenterol       Date:  2018-07-28       Impact factor: 5.742

4.  Genetic Manipulation of Helicobacter pylori Virulence Function by Host Carcinogenic Phenotypes.

Authors:  Giovanni Suarez; Judith Romero-Gallo; Johanna C Sierra; M Blanca Piazuelo; Uma S Krishna; Martin A Gomez; Keith T Wilson; Richard M Peek
Journal:  Cancer Res       Date:  2017-02-16       Impact factor: 12.701

5.  Cancer Stem Cells: An Ever-Hiding Foe.

Authors:  Jacek R Wilczyński
Journal:  Exp Suppl       Date:  2022

6.  IL-17 Receptor Signaling through IL-17A or IL-17F Is Sufficient to Maintain Innate Response and Control of Helicobacter pylori Immunopathogenesis.

Authors:  Beverly R E A Dixon; Tiffany J Lee; Diana C Contreras Healey; Jing Li; Jeremy A Goettel; M Blanca Piazuelo; Holly M Scott Algood
Journal:  Immunohorizons       Date:  2022-02-10

7.  Early life socioeconomic position and immune response to persistent infections among elderly Latinos.

Authors:  Helen C S Meier; Mary N Haan; Carlos F Mendes de Leon; Amanda M Simanek; Jennifer B Dowd; Allison E Aiello
Journal:  Soc Sci Med       Date:  2016-07-05       Impact factor: 4.634

Review 8.  Intestinal eosinophils, homeostasis and response to bacterial intrusion.

Authors:  Alessandra Gurtner; Ignacio Gonzalez-Perez; Isabelle C Arnold
Journal:  Semin Immunopathol       Date:  2021-04-30       Impact factor: 9.623

Review 9.  Regulatory T-Cells at the Interface between Human Host and Pathogens in Infectious Diseases and Vaccination.

Authors:  Mardi C Boer; Simone A Joosten; Tom H M Ottenhoff
Journal:  Front Immunol       Date:  2015-05-11       Impact factor: 7.561

10.  Fragmentation of CagA Reduces Hummingbird Phenotype Induction by Helicobactor pylori.

Authors:  Chih-Chi Chang; Wein-Shung Kuo; Ying-Chieh Chen; Chin-Lin Perng; Hwai-Jeng Lin; Yueh-Hsing Ou
Journal:  PLoS One       Date:  2016-03-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.